|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| C07D 403/12 | (2006.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 403/14 | (2006.01) |
| (11) | Number of the document | 1463506 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02788214.1 |
| Date of filing the European patent application | 2002-12-20 | |
| (97) | Date of publication of the European application | 2004-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2009-10-21 |
| (46) | Date of publication of the claims translation | 2010-01-25 |
| (86) | Number | PCT/GB2002/005845 |
| Date | 2002-12-20 |
| (87) | Number | WO 2003/055491 |
| Date | 2003-07-10 |
| (30) | Number | Date | Country code |
| 01403357 | 2001-12-24 | EP |
| (72) |
JUNG, Frederic Henri, FR
PASQUET, Georges Rene, FR
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Pakeistieji chinazolino dariniai kaip Aurora kinazės slopikliai |
| SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES |
| Payment date | Validity (years) | Amount | |
| 2021-11-24 | 347.00 EUR |